These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1979217)

  • 1. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    McKenna DJ; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies.
    De Souza EB; Battaglia G; Insel TR
    Ann N Y Acad Sci; 1990; 600():682-97; discussion 697-8. PubMed ID: 1979218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K; Maeda H; Goromaru T
    Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytopathologic features indicative of 5-hydroxytryptamine axon degeneration are observed in rat brain after administration of d- and l-methylenedioxyamphetamine.
    Axt KJ; Mullen CA; Molliver ME
    Ann N Y Acad Sci; 1992 May; 648():244-7. PubMed ID: 1637051
    [No Abstract]   [Full Text] [Related]  

  • 6. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Lehmann J; DeSouza EB; Culp S; Zaczek R
    Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurochemical basis of neurotoxicity.
    Gibb JW; Johnson M; Hanson GR
    Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C; Bravo G; Walsh R
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract]   [Full Text] [Related]  

  • 10. Biogenic amines as biomarkers for neurotoxicity.
    Ali SF; Chang LW; Slikker W
    Biomed Environ Sci; 1991 Jun; 4(1-2):207-16. PubMed ID: 1680343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of MDMA-like substances.
    Nichols DE; Oberlender R
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1990 May; 181(1-2):59-70. PubMed ID: 1974858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDMA: historical perspectives.
    Gibb JW; Johnson M; Stone D; Hanson GR
    Ann N Y Acad Sci; 1990; 600():601-11; discussion 611-2. PubMed ID: 1979213
    [No Abstract]   [Full Text] [Related]  

  • 14. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
    Steele TD; McCann UD; Ricaurte GA
    Addiction; 1994 May; 89(5):539-51. PubMed ID: 7913850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
    St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
    Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):539-44. PubMed ID: 1676847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM; Johnson M; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.